• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CARM1 通过甲基化 GAPDH 来调节葡萄糖代谢,并且在肝癌中受到抑制。

CARM1 Methylates GAPDH to Regulate Glucose Metabolism and Is Suppressed in Liver Cancer.

机构信息

Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, 131 Dong'an Road, Shanghai 200032, China.

Cancer Institute, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong'an Road, Shanghai 200032, China; Cancer Metabolism Laboratory, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, 131 Dong'an Road, Shanghai 200032, China.

出版信息

Cell Rep. 2018 Sep 18;24(12):3207-3223. doi: 10.1016/j.celrep.2018.08.066.

DOI:10.1016/j.celrep.2018.08.066
PMID:30232003
Abstract

Increased aerobic glycolysis is a hallmark of cancer metabolism. How cancer cells coordinate glucose metabolism with extracellular glucose levels remains largely unknown. Here, we report that coactivator-associated arginine methyltransferase 1 (CARM1 or PRMT4) signals glucose availability to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and suppresses glycolysis in liver cancer cells. CARM1 methylates GAPDH at arginine 234 (R234), inhibiting its catalytic activity. Glucose starvation leads to CARM1 upregulation, further inducing R234 hypermethylation and GAPDH inhibition. The re-expression of wild-type GAPDH, but not of its methylation-mimetic mutant, sustains glycolytic levels. CARM1 inhibition increases glycolytic flux and glycolysis. R234 methylation delays tumor cell proliferation in vitro and in vivo. Compared with normal tissues, R234 is hypomethylated in malignant clinical hepatocellular carcinoma samples. Notably, R234 methylation positively correlates with CARM1 expression in these liver cancer samples. Our findings thus reveal that CARM1-mediated GAPDH methylation is a key regulatory mechanism of glucose metabolism in liver cancer.

摘要

糖酵解增加是癌症代谢的一个标志。癌细胞如何将葡萄糖代谢与细胞外葡萄糖水平相协调在很大程度上尚不清楚。在这里,我们报告共激活因子相关精氨酸甲基转移酶 1(CARM1 或 PRMT4)将葡萄糖可用性信号传递给甘油醛-3-磷酸脱氢酶(GAPDH),并抑制肝癌细胞中的糖酵解。CARM1 在精氨酸 234(R234)处使 GAPDH 甲基化,抑制其催化活性。葡萄糖饥饿导致 CARM1 上调,进一步诱导 R234 过度甲基化和 GAPDH 抑制。野生型 GAPDH 的重新表达,但不是其甲基化模拟突变体的表达,维持了糖酵解水平。CARM1 抑制增加了糖酵解通量和糖酵解。R234 甲基化在体外和体内延迟了肿瘤细胞的增殖。与正常组织相比,恶性临床肝细胞癌样本中的 R234 呈低甲基化。值得注意的是,R234 甲基化与这些肝癌样本中的 CARM1 表达呈正相关。因此,我们的发现揭示了 CARM1 介导的 GAPDH 甲基化是肝癌中葡萄糖代谢的关键调节机制。

相似文献

1
CARM1 Methylates GAPDH to Regulate Glucose Metabolism and Is Suppressed in Liver Cancer.CARM1 通过甲基化 GAPDH 来调节葡萄糖代谢,并且在肝癌中受到抑制。
Cell Rep. 2018 Sep 18;24(12):3207-3223. doi: 10.1016/j.celrep.2018.08.066.
2
Arginine Methylation of MDH1 by CARM1 Inhibits Glutamine Metabolism and Suppresses Pancreatic Cancer.精氨酸甲基转移酶 CARM1 对 MDH1 的甲基化抑制谷氨酰胺代谢并抑制胰腺癌。
Mol Cell. 2016 Nov 17;64(4):673-687. doi: 10.1016/j.molcel.2016.09.028. Epub 2016 Nov 10.
3
CARM1 suppresses serine synthesis by promoting PKM2 activity.CARM1 通过促进 PKM2 的活性来抑制丝氨酸的合成。
J Biol Chem. 2018 Sep 28;293(39):15290-15303. doi: 10.1074/jbc.RA118.004512. Epub 2018 Aug 21.
4
GAPDH with NAD-binding site mutation competitively inhibits the wild-type and affects glucose metabolism in cancer.具有 NAD 结合位点突变的 GAPDH 竞争性抑制野生型并影响癌症中的葡萄糖代谢。
Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2555-2563. doi: 10.1016/j.bbagen.2018.08.001. Epub 2018 Aug 3.
5
The NRF2-CARM1 axis links glucose sensing to transcriptional and epigenetic regulation of the pentose phosphate pathway in gastric cancer.NRF2-CARM1 轴将葡萄糖感应与胃癌中戊糖磷酸途径的转录和表观遗传调控联系起来。
Cell Death Dis. 2024 Sep 12;15(9):670. doi: 10.1038/s41419-024-07052-3.
6
Pontin arginine methylation by CARM1 is crucial for epigenetic regulation of autophagy.CARMI 介导的脑桥核蛋白精氨酸甲基化对自噬的表观遗传调控至关重要。
Nat Commun. 2020 Dec 8;11(1):6297. doi: 10.1038/s41467-020-20080-9.
7
Arginine methylation of PPP1CA by CARM1 regulates glucose metabolism and affects osteogenic differentiation and osteoclastic differentiation.精氨酸甲基化的 PPP1CA 由 CARM1 调节葡萄糖代谢,并影响成骨分化和破骨细胞分化。
Clin Transl Med. 2023 Sep;13(9):e1369. doi: 10.1002/ctm2.1369.
8
Determining the quantitative relationship between glycolysis and GAPDH in cancer cells exhibiting the Warburg effect.测定表现出瓦博格效应的癌细胞中糖酵解和 GAPDH 之间的定量关系。
J Biol Chem. 2021 Jan-Jun;296:100369. doi: 10.1016/j.jbc.2021.100369. Epub 2021 Feb 3.
9
CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis-Driven Hepatocarcinogenesis via ERK-Dependent PKM2 Nuclear Relocalization and Activation.PRMT6 通过 CRAF 甲基化调控 ERK 依赖的 PKM2 核转位和激活来驱动有氧糖酵解促进肝癌发生。
Hepatology. 2020 Apr;71(4):1279-1296. doi: 10.1002/hep.30923. Epub 2020 Jan 24.
10
Arginine methylation of ribose-5-phosphate isomerase A senses glucose to promote human colorectal cancer cell survival.核糖-5-磷酸异构酶 A 的精氨酸甲基化感知葡萄糖以促进人结直肠癌细胞存活。
Sci China Life Sci. 2020 Sep;63(9):1394-1405. doi: 10.1007/s11427-019-1562-y. Epub 2020 Mar 6.

引用本文的文献

1
The Epstein-Barr virus EBNA1 protein binds to G-quadruplexes in its own mRNA hence controlling its expression and immune evasion of the virus.爱泼斯坦-巴尔病毒EBNA1蛋白与其自身mRNA中的G-四链体结合,从而控制病毒的表达和免疫逃逸。
Nucleic Acids Res. 2025 Jun 20;53(12). doi: 10.1093/nar/gkaf586.
2
Bioactive metallic nanoparticles for synergistic cancer immunotherapy.用于协同癌症免疫治疗的生物活性金属纳米颗粒。
Acta Pharm Sin B. 2025 Apr;15(4):1869-1911. doi: 10.1016/j.apsb.2025.02.022. Epub 2025 Feb 21.
3
Fenvalerate exposure induces AKT/AMPK-dependent alterations in glucose metabolism in hepatoma cells.
氰戊菊酯暴露诱导肝癌细胞葡萄糖代谢中依赖AKT/AMPK的改变。
Front Pharmacol. 2025 Feb 25;16:1540567. doi: 10.3389/fphar.2025.1540567. eCollection 2025.
4
PSMD14-mediated deubiquitination of CARM1 facilitates the proliferation and metastasis of hepatocellular carcinoma by inducing the transcriptional activation of FERMT1.PSMD14介导的CARM1去泛素化通过诱导FERMT1的转录激活促进肝细胞癌的增殖和转移。
Cell Death Dis. 2025 Feb 27;16(1):141. doi: 10.1038/s41419-025-07416-3.
5
Metabolic reprogramming of glucose: the metabolic basis for the occurrence and development of hepatocellular carcinoma.葡萄糖的代谢重编程:肝细胞癌发生发展的代谢基础。
Front Oncol. 2025 Feb 6;15:1545086. doi: 10.3389/fonc.2025.1545086. eCollection 2025.
6
PRMT3 and CARM1: Emerging Epigenetic Targets in Cancer.PRMT3和CARM1:癌症中新兴的表观遗传靶点。
J Cell Mol Med. 2025 Feb;29(4):e70386. doi: 10.1111/jcmm.70386.
7
CARM1-mediated OGT arginine methylation promotes non-small cell lung cancer glycolysis by stabilizing OGT.CARM1介导的OGT精氨酸甲基化通过稳定OGT促进非小细胞肺癌糖酵解。
Cell Death Dis. 2024 Dec 23;15(12):927. doi: 10.1038/s41419-024-07313-1.
8
Targeting the mTOR Pathway in Hepatocellular Carcinoma: The Therapeutic Potential of Natural Products.靶向肝细胞癌中的mTOR信号通路:天然产物的治疗潜力
J Inflamm Res. 2024 Dec 6;17:10421-10440. doi: 10.2147/JIR.S501270. eCollection 2024.
9
An overview of invasive micropapillary carcinoma of the breast: past, present, and future.乳腺浸润性微乳头状癌概述:过去、现在与未来
Front Oncol. 2024 Nov 15;14:1435421. doi: 10.3389/fonc.2024.1435421. eCollection 2024.
10
Redox-sensitive epigenetic activation of SUV39H1 contributes to liver ischemia-reperfusion injury.SUV39H1的氧化还原敏感型表观遗传激活导致肝脏缺血再灌注损伤。
Redox Biol. 2024 Dec;78:103414. doi: 10.1016/j.redox.2024.103414. Epub 2024 Oct 31.